Advanced Bitcoin Technologies AG Q4 FY2024 Earnings Call

· Earnings call transcript and AI-powered summary

  • Headline Results: Abbott posted strong Q4 2024 results with organic sales growth of 10% excluding COVID testing. Adjusted earnings per share (EPS) grew 13% year-over-year.
  • Full-Year 2024 Highlights:
    • Organic sales growth of 9.5% excluding COVID-related testing.
    • Improved gross margin by 70 basis points to 56.9%.
    • Operating cash flow totaled $8.5 billion, with $5 billion returned to shareholders via dividends and repurchases.
    • Annual EPS finished at the high end of guidance.
  • 2025 Guidance:
    • Organic sales growth of 7.5–8.5%.
    • Adjusted EPS forecasted at $5.05 to $5.25, reflecting double-digit growth at the midpoint.
    • First quarter 2025 EPS guidance: $1.05–$1.09.
    • Gross margin expected to improve 80 bps to ~57%.
    • Operating margin projected between 23.5%–24%, up 150 bps YoY.
    • Adjusted tax rate projected to rise to 16–17% due to Pillar 2 global tax framework.

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participant’s questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott’s express written permission. I would now like to introduce Mr. Mike Comilla, Vice President, Investor Relations. Mike Comilla: Good morning and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer; and Phil Boudreau, Executive Vice President, Finance and Chief Financial Officer. Robert and Phil will provide opening remarks. Following their comments, we’ll take your questions. Before we get started, some statements made today may be forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2025. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological, and other factors that may affect Abbott’s operations are discussed in Item 1A, Risk Factors, to our annual re

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional